NCT00802035View on ClinicalTrials.gov

ALK29-002: A Study of Baclofen Formulations in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

February 28, 2009

Conditions
Alcohol Dependence
Interventions
DRUG

Baclofen IR

30 mg; single dose

DRUG

Baclofen ER

30 mg; single dose

Trial Locations (1)

78759

CEDRA Clinical Research, LLC, Austin

Sponsors

Lead Sponsor

Alkermes, Inc.
All Listed Sponsors
lead

Alkermes, Inc.

INDUSTRY